Michael O. Falster
About
Michael O. Falster is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Epidemiology.
According to data from OpenAlex, Michael O. Falster has authored 66 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Economics and Econometrics, 19 papers in Cardiology and Cardiovascular Medicine and 17 papers in Epidemiology. Recurrent topics in Michael O. Falster's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Healthcare Policy and Management (10 papers) and Chronic Disease Management Strategies (8 papers). Michael O. Falster is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Healthcare Policy and Management (10 papers) and Chronic Disease Management Strategies (8 papers). Michael O. Falster collaborates with scholars based in Australia, United Kingdom and United States. Michael O. Falster's co-authors include Claire M. Vajdic, Marina T. van Leeuwen, Andrew E. Grulich, Louisa Jorm, Sallie‐Anne Pearson, Bich Tran, Jim Warren, Amy Page, Christopher Etherton‐Beer and Alastair H. Leyland and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.
In The Last Decade
Michael O. Falster
59 papers receiving 2.6k citations
Hit Papers
Peers
Michael O. Falster
Derek Weycker United States
Sameer D. Saini United States
Arjun Gupta United States
Huifeng Yun United States
Edgar P. Simard United States
Mark Tacey Australia
Andrew Artz United States
Tamar H. Taddei United States
M. Kessler France
Catherine D. Cooksley United States
Citations per year, relative to Michael O. Falster Michael O. Falster (= 1×)
peers
Derek Weycker
Countries citing papers authored by Michael O. Falster
Since
Specialization
Citations
This map shows the geographic impact of Michael O. Falster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael O. Falster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael O. Falster more than expected).
Fields of papers citing papers by Michael O. Falster
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Michael O. Falster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael O. Falster. The network helps show where Michael O. Falster may publish in the future.
Co-authorship network of co-authors of Michael O. Falster
This figure shows the co-authorship network connecting the top 25 collaborators of Michael O. Falster. A scholar is included among the top collaborators of Michael O. Falster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael O. Falster. Michael O. Falster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lin, Jialing, Claire T. Deakin, Juliana de Oliveira Costa, et al.. (2025). Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study. Diabetes Research and Clinical Practice. 224. 112242–112242.
2.
Neuen, Brendon L., John W. Ostrominski, Brian Claggett, et al.. (2024). Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes. Journal of the American College of Cardiology. 84(22). 2246–2250.
3.
Daniels, Benjamin, Tim Luckett, Winston Liauw, et al.. (2024). Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study. Journal of Pain and Symptom Management. 68(3). 282–291.e11.
4.
Costa, Juliana de Oliveira, Jialing Lin, Jerry R. Greenfield, et al.. (2024). Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia . Diabetes Obesity and Metabolism. 26(7). 2787–2795.
5.
Lin, Jialing, Sallie‐Anne Pearson, Jerry R. Greenfield, et al.. (2024). Use of, time to, and type of first add‐on anti‐hyperglycaemic therapy to metformin in Australia, 2018–2022. British Journal of Clinical Pharmacology. 91(1). 117–126.
6.
Zoëga, Helga, Michael O. Falster, M. Gillies, et al.. (2024). The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia. Pharmacoepidemiology and Drug Safety. 33(8). e5887–e5887.
7.
Deakin, Claire T., Juliana de Oliveira Costa, David Brieger, et al.. (2024). Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22. European Heart Journal - Quality of Care and Clinical Outcomes. 11(3). 259–270.
8.
Neuen, Brendon L., Hiddo J.L. Heerspink, Priya Vart, et al.. (2023). Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria. Circulation. 149(6). 450–462.
9.
Costa, Juliana de Oliveira, Sallie‐Anne Pearson, David Brieger, et al.. (2023). In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals. International Journal for Equity in Health. 22(1). 226–226.
10.
Costa, Juliana de Oliveira, Jialing Lin, Sallie‐Anne Pearson, et al.. (2023). Persistence and Adherence to Cardiovascular Medicines in Australia. Journal of the American Heart Association. 12(13). e030264–e030264.
11.
Quiroz, Juan C., David Brieger, Louisa Jorm, et al.. (2022). An Observational Study of Clinical and Health System Factors Associated With Catheter Ablation and Early Ablation Treatment for Atrial Fibrillation in Australia. Heart Lung and Circulation. 31(9). 1269–1276.
12.
Falster, Michael O., Louisa Jorm, Barry Beiles, et al.. (2022). Editor's Choice – Comparison of Outcomes for Major Contemporary Endograft Devices Used for Endovascular Repair of Intact Abdominal Aortic Aneurysms. European Journal of Vascular and Endovascular Surgery. 65(2). 272–280.
13.
Falster, Michael O., et al.. (2022). Comparison of long-term outcomes of bioprosthetic and mechanical aortic valve replacement in patients younger than 65 years. Journal of Thoracic and Cardiovascular Surgery. 166(3). 728–737.e13.
14.
Costa, Juliana de Oliveira, Sallie‐Anne Pearson, Adam G. Elshaug, et al.. (2021). Rates of Low-Value Service in Australian Public Hospitals and the Association With Patient Insurance Status. JAMA Network Open. 4(12). e2138543–e2138543.
15.
Falster, Michael O., et al.. (2020). Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients. SHILAP Revista de lepidopterología. 2(1). e000036–e000036.
16.
Falster, Michael O., Alastair H. Leyland, & Louisa Jorm. (2019). Do hospitals influence geographic variation in admission for preventable hospitalisation? A data linkage study in New South Wales, Australia. BMJ Open. 9(2). e027639–e027639.
17.
Johnson, Tracy, et al.. (2018). Predictive risk modelling under different data access scenarios: who is identified as high risk and for how long?. BMJ Open. 8(2). e018909–e018909.
18.
Tran, Bich, Michael O. Falster, & Louisa Jorm. (2018). Claims-based measures of continuity of care have non-linear associations with health: data linkage study. International Journal for Population Data Science. 3(1). 463–463.
19.
Leeuwen, Marina T. van, Michael O. Falster, Claire M. Vajdic, et al.. (2018). Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data. BMJ Open. 8(4). e020858–e020858.
20.
Falster, Michael O., Louisa Jorm, & Alastair H. Leyland. (2016). Visualising linked health data to explore health events around preventable hospitalisations in NSW Australia. BMJ Open. 6(9). e012031–e012031.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Derek Weycker Breakdown of academic impact, for papers by Sameer D. Saini Breakdown of academic impact, for papers by Arjun Gupta Breakdown of academic impact, for papers by Huifeng Yun Breakdown of academic impact, for papers by Edgar P. Simard Breakdown of academic impact, for papers by Mark Tacey Breakdown of academic impact, for papers by Andrew Artz Breakdown of academic impact, for papers by Tamar H. Taddei Breakdown of academic impact, for papers by M. Kessler Breakdown of academic impact, for papers by Catherine D. Cooksley